(1 - 8 from 11
)
Illumina Names Dr. Phil Febbo Chief Medical Officer
www.sharewise.com
Illumina, Inc. (NASDAQ:ILMN) announced today the appointment of Dr. Phil Febbo, a leading physician scientist, as Chief Medical Officer (CMO), starting March 26, In his new role, Dr. Febbo will be responsible for developing and executing on the Company's medical strategy to drive genomic testing into healthcare ...
Illumina appoints Dr. Phil Febbo as Chief Medical Officer
www.pharmajournalist.com
Illumina asserted the appointment of Dr. Phil Febbo who is a Leading physician scientist, as Chief Medical Officer (CMO), starting March 26, In his new role, Dr. Febbo will be responsible for developing and executing on the Company's medical strategy to drive genomic testing into healthcare practice.
Cleveland Clinic Innovations - October 23, 2017
innovations.clevelandclinic.org
Phil Febbo, MD, CMO, Genomic Health, Inc. David Flannery, MD, Medical Director, American College Medical Genetics & Genomics Steve Miller, MD, SVP ...
BioCentury - Management tracks: Ipsen, Illumina
www.biocentury.com
Ipsen Group (Euronext:IPN; Pink:IPSEY) hired Ivana Magovcevic-Liebisch as EVP and CBO. She was EVP and chief strategy and corporate development officer at Axcella Health Inc. (Cambridge, Mass.).Genomics company Illumina Inc. (NASDAQ:ILMN) hired Phil Febbo as CMO, effective March 26.
sorted by relevance / date